ERBB2 and breast carcinoma: Approximately 15% of all breast cancers are composed of Basal-like breast cancer (BLBC), characterized by a lack of expression of ER/PR/HER2 and the presence of basal cytokeratins and c-Kit (Badowska-Kozakiewicz and Budzik 2016).